ProtAb For Profit

ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways.

Last Funding Type: Venture - Series Unknown
Funding Status: Early Stage Venture
Headquarters: Jerusalem, Yerushalayim, Israel
Founded Date: 1905-06-27
Investor Type: For Profit
Technology: Biomarker panels
Employee Number: Jerusalem, Yerushalayim, Israel
Estimated Revenue: Less than $1M
Investors Number: 1
Industry: Clinical Data Management